To include your compound in the COVID-19 Resource Center, submit it here.

MoxDuo IR morphine/oxycodone: Completed Phase III enrollment

QRxPharma completed enrollment of 375 patients in the double-blind, U.S. Phase III Study 022

Read the full 146 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE